0001104659-14-041402.txt : 20140523 0001104659-14-041402.hdr.sgml : 20140523 20140523160026 ACCESSION NUMBER: 0001104659-14-041402 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140514 FILED AS OF DATE: 20140523 DATE AS OF CHANGE: 20140523 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fibrocell Science, Inc. CENTRAL INDEX KEY: 0000357097 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870458888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 405 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 484-713-6000 MAIL ADDRESS: STREET 1: 405 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: ISOLAGEN INC DATE OF NAME CHANGE: 20020320 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /DE DATE OF NAME CHANGE: 19960330 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /CO DATE OF NAME CHANGE: 19921008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Maslowski John Michael CENTRAL INDEX KEY: 0001608774 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31564 FILM NUMBER: 14867192 MAIL ADDRESS: STREET 1: 404 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 3 1 a3.xml 3 X0206 3 2014-05-14 0 0000357097 Fibrocell Science, Inc. FCSC 0001608774 Maslowski John Michael 405 EAGLEVIEW BOULEVARD EXTON PA 19341 0 1 0 0 V.P., Scientific Affairs Common Stock 480 D Option to Purchase Common Stock 18.75 2019-10-06 Common Stock 4000 D Option to Purchase Common Stock 15.50 2021-01-14 Common Stock 13600 D Option to Purchase Common Stock 5.49 2023-07-19 Common Stock 17500 D Option to Purchase Common Stock 4.95 2024-01-17 Common Stock 20000 D Option to Purchase Common Stock 2.94 2024-05-13 Common Stock 20000 D Warrant to Purchase Common Stock 6.25 2011-01-21 2016-12-31 Common Stock 960 D 50% of the Option to Purchase Common Stock vested on October 6, 2010 and 50% of the Option to Purchase Common Stock vested on the date the Issuer received approval for azficel-T. 50% of the Option to Purchase Common Stock vested on January 14, 2011, 25% of the Option to Purchase Common Stock vested on January 14, 2012 and 25% of the Option to Purchase Common Stock vested on January 14, 2013. 25% of the Option to Purchase Common Stock vested on July 19, 2013, 25% of the Option to Purchase Common Stock will vest on July 19, 2014, 25% of the Option to Purchase Common Stock will vest on July 19, 2015 and 25% of the Option to Purchase Common Stock will vest on July 19, 2016; in each case provided the reporting person is providing services to the Issuer on each vesting date. 25% of the Option to Purchase Common Stock will vest on January 17, 2015, 25% of the Option to Purchase Common Stock will vest on January 17, 2016, 25% of the Option to Purchase Common Stock will vest on January 17, 2017, and 25% of the Option to Purchase Common Stock will vest on January 17, 2018; in each case provided the reporting person is providing services to the Issuer on each vesting date. 25% of the Option to Purchase Common Stock will vest on May 13, 2015, 25% of the Option to Purchase Common Stock will vest on May 13, 2016, 25% of the Option to Purchase Common Stock will vest on May 13, 2017, and 25% of the Option to Purchase Common Stock will vest on May 13, 2018; in each case provided the reporting person is providing services to the Issuer on each vesting date. /s/ John Maslowski 2014-05-23